Inhibition of growh of Chlamydia trachomatis by the calcium antagonist verapamil

R. Shainkin-Kestenbaum, Y. Winikoff, R. Kol, C. Chaimovitz, I. Sarov

    Research output: Contribution to journalArticlepeer-review

    5 Scopus citations

    Abstract

    Treatment of BGM (African Green Monkey kidney) cells with the calcium antagonist Verapamil resulted in a reduced yield of chlamydial infectious particles. The inhibitory effect was concentration-dependent, the maximal effect being achieved at 200 μM-Verapamil, which produced a 99.99% reduction of infectious particle yield. Electron microscopy showed that control Chlamydia trachomatis-infected BGM cells contained typical large inclusions in which most of the particles were elementary bodies, whereas Verapamil-treated infected cells contained small inclusions consisting predominantly of reticulate bodies. The findings indicate a possible therapeutic use of this calcium antagonist as an anti-chlamydial drug.

    Original languageEnglish
    Pages (from-to)1619-1623
    Number of pages5
    JournalJournal of General Microbiology
    Volume135
    Issue number6
    StatePublished - 1 Jan 1989

    ASJC Scopus subject areas

    • Microbiology

    Fingerprint

    Dive into the research topics of 'Inhibition of growh of Chlamydia trachomatis by the calcium antagonist verapamil'. Together they form a unique fingerprint.

    Cite this